Back to Search
Start Over
A 10-year open follow-up of eczema and respiratory symptoms in patients with atopic dermatitis treated with topical tacrolimus for the first 4 years.
- Source :
-
Journal of Dermatological Treatment . May2010, Vol. 21 Issue 3, p167-170. 4p. 1 Chart, 1 Graph. - Publication Year :
- 2010
-
Abstract
- Objectives: To examine the 10-year outcome of affected body surface area (BSA), respiratory symptoms, and serum IgE in adult AD patients 6 years after a 4-year intervention with topical tacrolimus. Methods: Patients who 10 years ago participated in a 4-year, open tacrolimus study ( n = 65) were contacted for assessment of affected BSA, bronchial hyper-reactivity (BHR), respiratory symptoms, skin prick tests and serum IgE. Results: Altogether, 50 (77%) patients attended the follow-up visit. The median affected BSA decreased from 19% to 1.6% during the 10-year follow-up ( p < 0.0001). Patients with active asthma and rhinitis symptoms at baseline reported a significant decrease at the follow-up ( p = 0.02 and p = 0.01). In patients with BHR at baseline, the provocative dose of inhaled histamine producing a 15% decrease in FEV1 increased. Responders (≥ 60% improvement of affected BSA) to tacrolimus treatment at the 1-year visit had a significantly smaller affected BSA at the 4- and 10-year visits than non-responders (< 60% improvement). Responders also showed a significant decrease in serum IgE at the follow-up visit compared to baseline ( p = 0.002). Conclusions: The long-term, effective treatment of patients with AD may have a beneficial effect on affected BSA, respiratory symptoms, and serum IgE. [ABSTRACT FROM AUTHOR]
- Subjects :
- *SKIN inflammation
*TACROLIMUS
*ATOPIC dermatitis
*ECZEMA
*BLOOD plasma
Subjects
Details
- Language :
- English
- ISSN :
- 09546634
- Volume :
- 21
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- Journal of Dermatological Treatment
- Publication Type :
- Academic Journal
- Accession number :
- 83257421
- Full Text :
- https://doi.org/10.3109/09546630903493329